0001437749-25-033325.txt : 20251105 0001437749-25-033325.hdr.sgml : 20251105 20251105154330 ACCESSION NUMBER: 0001437749-25-033325 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251105 DATE AS OF CHANGE: 20251105 EFFECTIVENESS DATE: 20251105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Luminary Therapeutics, Inc. CENTRAL INDEX KEY: 0001793860 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563183 FILM NUMBER: 251453624 BUSINESS ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 D 1 primary_doc.xml X0708 D LIVE 0001793860 Luminary Therapeutics, Inc. 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 612-309-7653 DELAWARE None None Corporation true Jeff Liter 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Executive Officer Director Promoter John Wells 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director James Haymaker 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Promoter Tracey Lodie 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Mark Chance 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Jeff Ross 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Branden Moriarity 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Biotechnology Decline to Disclose 06b false 2025-10-14 true true true true false 0 12388157 1406112 10982045 3(a) and (b) include the conversion of approximately $581,127 in previously issued SAFEs, which will occur when the Company has sold $3,000,000 in shares of Series B-1 Preferred; 13(a) and (c) include the issuance of warrants. false 6 0 0 0 false Luminary Therapeutics, Inc. /s/ Jeff Liter Jeff Liter President and Chief Executive Officer 2025-11-05